First Page | Document Content | |
---|---|---|
Date: 2015-04-22 23:39:46Immunosuppressants Medicine Cytokines Autoimmune diseases Treatment of multiple sclerosis Glatiramer acetate Natalizumab Fingolimod Interferon beta-1a Immunology Immune system Multiple sclerosis | Microsoft Word - Sanofi- 5.1 alemtuzumabPSD final.docxAdd to Reading ListSource URL: www.pbs.gov.auDownload Document from Source WebsiteFile Size: 205,06 KBShare Document on Facebook |
Guideline on clinical investigation of medicinal products for the treatment of Multiple Sclerosis rev. 2DocID: 1rmwo - View Document | |
PDF DocumentDocID: 1rhTx - View Document | |
PDF DocumentDocID: 1ptj0 - View Document | |
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION Pr COPAXONE® Glatiramer acetateDocID: 1kIzm - View Document | |
Biotin (Cerenday) for permanent disability related to multiple sclerosis relapses – add on therapy to current immunomodulatorsDocID: 1fWCE - View Document |